A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

被引：2
|
作者：
Qian, Jiejing [1 ]
Xu, Jieyu [1 ,2 ]
Hong, Qing [1 ,2 ]
Lou, Yinjun [1 ]
Mao, Liping [1 ]
Xu, Weilai [1 ]
Yang, Min [3 ]
Yu, Wenjuan [1 ,4 ]
Meng, Haitao [1 ]
Mai, Wenyuan
Ye, Xiujing [5 ]
Zhu, Honghu [1 ]
Jin, Jie [1 ,6 ,7 ,8 ,9 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[5] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[6] Key Lab Hematol Malignancies Diag & Treatment, Hangzhou, Peoples R China
[7] Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China
[8] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China
[9] Clin Res Ctr Hematol Disorders, Hangzhou, Zhejiang, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4414
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    DiNardo, Courtney D.
    Pratz, Keith
    Pullarkat, Vinod
    Jonas, Brian A.
    Arellano, Martha
    Becker, Pamela S.
    Frankfurt, Olga
    Konopleva, Marina
    Wei, Andrew H.
    Kantarjian, Hagop M.
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Potluri, Jalaja
    Pollyea, Daniel A.
    Letai, Anthony
    BLOOD, 2019, 133 (01) : 7 - 17
  • [42] Outcomes in Chemotherapy-Ineligible Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Plus Azacitidine: A Pooled Analysis
    Venditti, Adriano
    Hou, Jing-Zhou
    Fenaux, Pierre
    Jonas, Brian A.
    Vrhovac, Radovan
    Montesinos, Pau
    Garcia, Jacqueline S.
    Rizzieri, David
    Thirman, Michael J.
    Kotey, Stanley
    Potluri, Jalaja
    Dhalla, Mazaher
    Pullarkat, Vinod
    BLOOD, 2023, 142
  • [43] Homoharringtonine Combining with Azacitidine and Venetoclax (HAV) As First-Line Induction Therapy for Newly Diagnosed Adult Acute Myeloid Leukemia Patients
    Lu, Wenyi
    Chen, Xiangli
    Zang, Yuzhu
    Zhu, Zunmin
    Zhang, Wenhui
    Hai, Yanliang
    Chen, Yuqing
    Jiang, Li
    Xing, Yanyan
    Liu, Yuanbo
    Shi, Jie
    Gao, Zhenxing
    BLOOD, 2024, 144 : 6037 - 6037
  • [44] Outcomes and Survival in Newly Diagnosed, Older, Acute Myeloid Leukemia Patients from the Beat AML Master Trial in the Venetoclax/Azacitidine Age
    Borate, Uma
    Huang, Ying
    Li Welkie, Rina
    Swords, Ronan T.
    Traer, Elie
    Stein, Eytan M.
    Lin, Tara L.
    Madanat, Yazan F.
    Patel, Prapti A.
    Collins, Robert H.
    Baer, Maria R.
    Duong, Vu H.
    Blum, William
    Arellano, Martha L.
    Stock, Wendy
    Odenike, Olatoyosi
    Redner, Robert L.
    Kovacsovics, Tibor J.
    Deininger, Michael W.
    Zeidner, Joshua F.
    Olin, Rebecca
    Smith, Catherine C.
    Foran, James M.
    Schiller, Gary J.
    Curran, Emily K.
    Koenig, Kristin L.
    Heerema, Nyla A.
    Chen, Timothy
    Martycz, Molly
    Stefanos, Mona
    Marcus, Sonja Gullen
    Druker, Brian J.
    Levine, Ross L.
    Burd, Amy
    Rossenber, Leohard
    Yocum, Ashley Owen
    Mims, Alice
    Byrd, John C.
    BLOOD, 2024, 144 : 4324 - 4326
  • [45] Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
    Matthews, Andrew H.
    Perl, Alexander E.
    Luger, Selina M.
    Loren, Alison W.
    Gill, Saar I.
    Porter, David L.
    Babushok, Daria V.
    Maillard, Ivan P.
    Carroll, Martin P.
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Stadtmauer, Edward A.
    Paralkar, Vikram R.
    Bruno, Ximena Jordan
    Hwang, Wei -Ting
    Margolis, David
    Pratz, Keith W.
    BLOOD ADVANCES, 2022, 6 (13) : 3997 - 4005
  • [46] A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia
    Hu, Rong-Hua
    Su, Li
    Lan, Xiao-Xi
    Chang, Xiao-Li
    Hui, Wu-Han
    Guo, Yi-Xian
    Zhao, Hong
    Zhang, Yue
    Sun, Wan-Ling
    ANTI-CANCER DRUGS, 2023, 34 (03) : 344 - 350
  • [47] A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Conventional Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia
    Fathi, Amir T.
    Fell, Geoffrey G.
    El-Jawahri, Areej
    Perl, Alexander E.
    Jonas, Brian A.
    Dias, Ajoy L.
    Mims, Alice S.
    Borate, Uma
    Ragon, Brittany Knick
    Grunwald, Michael R.
    Peters, Mary Linton B.
    Graubert, Timothy A.
    Amrein, Philip C.
    Hock, Hanno R.
    Brunner, Andrew M.
    Hobbs, Gabriela S.
    Narayan, Rupa
    Neuberg, Donna S.
    Aldoss, Ibrahim
    BLOOD, 2022, 140 : 3284 - 3286
  • [48] A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Alvarado, Yesid
    Chien, Kelly
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas
    Daver, Naval
    Issa, Ghayas
    Jain, Nitin
    Bull-Linderman, Debra
    DiNardo, Courtney
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S239 - S240
  • [49] Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study
    Miyashita, Naoki
    Onozawa, Masahiro
    Matsukawa, Toshihiro
    Mori, Akio
    Hidaka, Daisuke
    Minauchi, Koichiro
    Shigematsu, Akio
    Hashiguchi, Junichi
    Igarashi, Tetsuyuki
    Kakinoki, Yasutaka
    Tsutsumi, Yutaka
    Ibata, Makoto
    Wakasa, Kentaro
    Fujimoto, Katsuya
    Ishihara, Toshimichi
    Sakai, Hajime
    Iyama, Satoshi
    Oyake, Tatsuo
    Kondo, Takeshi
    Teshima, Takanori
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1549 - 1553
  • [50] Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Real-World Experience in Pharmacovigilance
    Burke, Mary
    Sallman, David A.
    Denson, Ariel
    Nelson, Rebecca Jean
    Chan, Onyee
    Walker, Alison R.
    Padron, Eric
    Xie, Zhuoer
    Komrokji, Rami S.
    Lancet, Jeffrey
    Kuykendall, Andrew T.
    Tobon, Katherine
    Jain, Akriti Gupta
    Wang, Chen
    Al Ali, Najla H.
    BLOOD, 2023, 142
12345